A
RMD icon

AlphaQuest’s ResMed RMD Stock Holding History

AlphaQuest’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,894
Closed -$1.66M – 1649
2025
Q4 		$1.66M Sell
6,894
-8,469
-55% -$2.17M 0.09% 239
2025
Q3 		$4.21M Buy
15,363
+14,013
+1,038% +$3.83M 0.27% 43
2025
Q2 		$348K Sell
1,350
-2,100
-61% -$501K 0.03% 799
2025
Q1 		$772K Buy
3,450
+488
+16% +$114K 0.08% 367
2024
Q4 		$677K Buy
2,962
+1,090
+58% +$262K 0.09% 362
2024
Q3 		$457K Buy
1,872
+1,545
+472% +$345K 0.04% 693
2024
Q2 		$62.6K Buy
327
+100
+44% +$20.3K 0.01% 1036
2024
Q1 		$45K Buy
+227
New +$41.6K 0.01% 944

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AlphaQuest's RMD Position: Q1 2026 in Review

AlphaQuest sold out of ResMed (RMD) in Q1 2026, closing a stake of 6,894 shares — an estimated $1.66M sold.

AlphaQuest first reported a position in RMD in Q1 2024 and held it in 8 quarters. The position peaked at $4.21M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • AlphaQuest reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 6,894 ResMed shares in Q1 2026, an estimated $1.66M.
  • AlphaQuest first reported a position in ResMed in Q1 2024 and held it in 8 quarters.
  • AlphaQuest's ResMed position peaked at $4.21M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.